PANORAMIS (SPINOSAD + MILBEMYCIN OXIME) CHEWABLE TABLETS FOR DOGS 4.6 - 9KG

País: Austrália

Língua: inglês

Origem: APVMA (Australian Pesticides and Veterinary Medicines Authority)

Ingredientes ativos:

SPINOSAD MANUFACTURING CONCENTRATE; MILBEMYCIN OXIME

Disponível em:

ELANCO AUSTRALASIA PTY LTD

DCI (Denominação Comum Internacional):

spinosad(270mg/Tb)+milbemycin oxime(4.5mg/Tb)

Forma farmacêutica:

ORAL TABLET

Composição:

SPINOSAD MANUFACTURING CONCENTRATE UNGROUPED Active 270.0 mg/Tb; MILBEMYCIN OXIME ANTIBIOTIC Active 4.5 mg/Tb

Unidades em pacote:

1 tablet; 3 tablets; 6 tablets

Classe:

VM - Veterinary Medicine

Fabricado por:

ELANCO ANIMAL HEALTH

Grupo terapêutico:

DOG | BITCH | CASTRATE | PUPPY

Área terapêutica:

V15C + V15F VET SMALL ANI

Indicações terapêuticas:

FLEA | FLEA ALLERGIC DERMATITIS | HEARTWORM - PREVENTION OF | HOOKWORM | ROUNDWORM | WHIPWORM - TRICHURIS SPP. | ANCYLOSTOMA BRAZILIENSE | ANCYLOSTOMA CANINUM | CTENOCEPHALIDES SPP. | GROUND FLEAS | TO PREVENT HEARTWORM | TOXOCARA MYSTAX | TOXOCARA SPP. | UNCINARIA STENOCEPHALA

Resumo do produto:

Poison schedule: 5; Withholding period: WHP: N/A; Host/pest details: DOG: [FLEA, FLEA ALLERGIC DERMATITIS, HEARTWORM - PREVENTION OF, HOOKWORM, ROUNDWORM, WHIPWORM - TRICHURIS SPP.]; For the prevention of heartworm disease; for the treatment, prevention and control of flea infestations and the control of flea allergy dermatitis; for the treatment and control of adult hookworm, roundworm and whipworm infections in dogs and puppiesNOT for use in puppies less than 8 weeks of age.

Status de autorização:

Registered

Data de autorização:

2023-07-01

Folheto informativo - Bula

ELANCO ANIMAL HEALTH A DIV OF ELI LILLY AUST PTY LTD
PANORAMIS (SPINOSAD + MILBEMYCIN OXIME) CHEWABLE TABLETS FOR
DOGS 4.6 - 9KG
65207/108402
COMPANY NAME:
PRODUCT NAME: APVMA APPROVAL NO:
LABEL NAME:
COMFORTIS PLUS (SPINOSAD + MILBEMYCIN OXIME) CHEWABLE TABLETS FOR
DOGS 4.6 - 9KG
SIGNAL HEADINGS:
CAUTION
KEEP OUT OF REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
READ SAFETY DIRECTIONS BEFORE OPENING OR USING
CONSTITUENT
STATEMENTS:
270 mg spinosad
4.5 mg milbemycin oxime
CLAIMS:
COMFORTIS PLUS is indicated for monthly administration for the
prevention of heartworm
disease (Dirofilaria immitis); for the treatment, prevention and
control of flea infestations
(Ctenocephalides felis) and the control of flea allergy dermatitis;
for treatment and control
of adult hookworm (Ancylostoma caninum), roundworm (Toxocara canis and
Toxascaris
leonina) and whipworm (Trichuris vulpis) infections in dogs and
puppies from eight weeks
of age, and 2.3kg body weight or greater.
NET CONTENTS:
1 chewable tablet, 3 chewable tablets, 6 chewable tablets
DIRECTIONS FOR USE:
RESTRAINTS:
CONTRAINDICATIONS:
PRECAUTIONS:
COMFORTIS PLUS should not be administered to puppies less than 8 weeks
of age.
Puppies less than 14 weeks of age may experience an increased rate of
vomiting. Seek
veterinary advice regarding the use of COMFORTIS PLUS in pregnant and
lactating
females, and in dogs with pre-existing epilepsy.
The safe use of COMFORTIS PLUS in breeding males has not been
evaluated.
Page 1 of 5 RLP APPROVED
Concurrent use of COMFORTIS PLUS with high extra-label doses of
ivermectin for
parasitic mange or demodicosis may be associated with an increased
risk of developing
neurological signs typically associated with ivermectin toxcitity.
COMFORTIS PLUS should not be administered concurrently with
extra-label high doses of
macrocyclic lactones.
The use of COMFORTIS PLUS in dogs suffering from microfilaremia is not
recommended.
On rare occasions, transient shock-like (hypersensitivity) reactions
have been observed
in heartworm positive animals carrying

Características técnicas

Issue date: 25-September-2015
Version number: 01
SAFETY DATA SHEET
1. Identification
Panoramis (Spinosad + Milbemycin Oxime) Chewable Tablets for Dogs 4.6
- 9 KG
Product identifier
Other means of identification
CA4337, CA4339, CA4341, CA4342, CA4344, CA4332, CA4333, CA4334,
CA4335, CA4336
Item Code
Recommended use of the chemical and restrictions on use
Veterinary Pharmaceutical
Recommended use
Not available.
Restrictions on use
Details of manufacturer or importer
Manufacturer
Company name
Elanco Animal Health
A Division of Eli Lilly Australia Pty Ltd
Address
A.B.N. 39 000 233 992
112 Wharf Road, West Ryde, N.S.W. 2114, Australia
Telephone
[phone]
Fax
[phone]
e-mail
[e-mail]
Emergency phone
number
Elanco Animal Health: 1800 226 324 (Toll free)
OR Poisons Information Centre: 131126 (Australia-wide)
24 hr emergency contact
number
CHEMWATCH 1800 039 008 (spills and accidents)
24 hr emergency contact
number (Local)
CHEMWATCH [phone] (spills and accidents)
2. Hazard(s) identification
Classification of the hazardous chemical
Not classified.
Physical hazards
Not classified.
Health hazards
Category 1
Hazardous to the aquatic environment, acute
hazard
Environmental hazards
Category 1
Hazardous to the aquatic environment,
long-term hazard
Label elements, including precautionary statements
Hazard symbol(s)
Environment
Signal word
Warning
Hazard Statement(s)
Very toxic to aquatic life with long lasting effects.
Precautionary Statement(s)
Prevention
Avoid release to the environment.
Response
Not available.
Storage
Not available.
Disposal
Not available.
Other hazards which do not
result in classification
None known.
Supplemental information
None.
1 / 9
Material name: Panoramis (Spinosad + Milbemycin Oxime) Chewable
Tablets for Dogs 4.6 - 9 KG
4510
SDS AUSTRALIA
3. Composition/information on ingredients
Mixture
Concentration of
ingredients
Identity of chemical ingredients
50
CAS number and
other unique
identifiers
131929-60-7
SPINOSYN A
9
131929-63-0
SPINOSYN D
0.7
93074-04-5
Milbemycin A4 5-ox